Generic drug
Glimepiride / pioglitazone price, strengths & recalls
Pharmacies pay $288.11 for 30 tablets of Glimepiride / pioglitazone 2 mg / 30 mg tablet this week, and from $288.11 to $309.63 across its 2 priced strengths and forms. Its official label last changed on December 15, 2025.
Generic- Fair cash price
- $341.83
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Glimepiride / pioglitazone price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 2 mg / 30 mg tablet | $9.60 | $288.11 / 30 tablets |
| 4 mg / 30 mg tablet | $10.32 | $309.63 / 30 tablets |
Supply status: shortages & recalls
What people paid for Glimepiride / pioglitazone
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use pioglitazone and glimepiride tablets safely and effectively. See full prescribing information for pioglitazone and glimepiride tablets. Pioglitazone and Glimepiride Tablets, for oral use Initial U.S. Approval: 2006
WARNING: CONGESTIVE HEART FAILURE
Thiazolidinediones, including pioglitazone, which is a component of pioglitazone and glimepiride tablets, cause or exacerbate congestive heart failure in some patients [see Warnings and Precautions (5.1)].
After initiation of pioglitazone and glimepiride tablets and after dose increases, monitor patients carefully for signs and symptoms of heart failure (e.g., excessive, rapid weight gain, dyspnea, and/or edema). If heart failure develops, it should be managed according to current standards of care and discontinuation or dose reduction of pioglitazone and glimepiride tablets must be considered [see Warnings and Precautions (5.1)].
Pioglitazone and glimepiride tablets are not recommended in patients with symptomatic heart failure [see Warnings and Precautions (5.1)].
Initiation of pioglitazone and glimepiride tablets in patients with established New York Heart Association (NYHA) Class III or IV heart failure is contraindicated [see Contraindications (4) and Warnings and Precautions (5.1)].
WARNING: CONGESTIVE HEART FAILURE
See full prescribing information for complete boxed warning.
Thiazolidinediones, including pioglitazone, which is a component of pioglitazone and glimepiride tablets, cause or exacerbate congestive heart failure in some patients. (5.1)
After initiation of pioglitazone and glimepiride tablets, and after dose increases, monitor patients carefully for signs and symptoms of heart failure (e.g., excessive, rapid weight gain, dyspnea, and/or edema). If heart failure develops, it should be managed according to current standards of care and discontinuation or dose reduction of pioglitazone and glimepiride tablets must be considered. (5.1)
Pioglitazone and glimepiride tablets are not recommended in patients with symptomatic heart failure. (5.1)
Initiation of pioglitazone and glimepiride tablets in patients with established New York Heart Association (NYHA) Class III or IV heart failure is contraindicated. (4, 5.1)
Recent major changes (as listed on the label)
Warnings and Precautions | |
Urinary Bladder Tumors (5.6) | 12/2016 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA021925 · Takeda Pharms USA
- First approved
- July 28, 2006 (20 years ago)
- Latest approved change
- December 21, 2017
- Approved label
- PDF, Dec 26, 2017
- Generic makers
- None on the market
- Last patent listed
- June 8, 2028
Glimepiride / pioglitazone questions
How much does glimepiride / pioglitazone cost without insurance?
Pharmacies pay about $288.11 for 30 tablets of glimepiride / pioglitazone 2 mg / 30 mg tablet ($9.60 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $341.83. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is glimepiride / pioglitazone in shortage?
No shortage is reported for glimepiride / pioglitazone right now. We check the national shortage list every day.
Has glimepiride / pioglitazone been recalled?
No recalls are on record for glimepiride / pioglitazone.
When did the glimepiride / pioglitazone label last change?
The official label was last updated on December 15, 2025 (version 9). See what changed.
Talk about glimepiride / pioglitazone
No comments yet. Questions, tips, what worked for you - start the conversation.